Dublin, May 01, 2020 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com published a new article on the healthcare industry, "COVID-19: 10 Companies at the Forefront of Antibody Test Development"
In order to understand the true scope of the pandemic, antibody tests are being introduced as the next step in responding to the outbreak.
Unlike Polymerase Chain Reaction (PCR) tests, antibody tests cannot be used to detect an active infection of COVID-19. Instead, these tests can detect specific antibodies in the blood to tell us who has already been infected and if they have developed some immunity to the virus.
Antibody testing is essential for identifying the exact numbers who have been infected with the COVID-19, especially those who did not experience symptoms and can give us an understanding of how many people are immune to COVID-19 and how long the immunity period lasts.
Understanding the percentage of the population who have already been exposed to the virus and developed an immunity to it will be very useful in helping to lift social-distancing rules.
Antibody testing can also be used for priority screening of essential workers such as healthcare personnel who may already have developed immunity and so could safely continue or return to work.
ResearchAndMarkets.com has identified 10 companies leading the way in antibody testing for COVID-19:
- Roche
- Biomedomics
- Eurofins
- Abbott Laboratories
- Mologic
- Biolidics
- Chembio
- Ortho Clinical
- Otogenetics
- Biomerica
To see the full article and a list of related reports on the healthcare industry, visit "COVID-19: 10 Companies at the Forefront of Antibody Test Development"
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.